Caladrius Bio (CLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CLBS | AMGN | VRTX | REGN | GILD |
Company | Caladrius Bio | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 9.7200 | 333.23 | 497.00 | 1,075.35 | 72.89 |
High | 9.7500 | 336.35 | 498.77 | 1,078.71 | 73.32 |
Low | 5.7300 | 332.47 | 492.00 | 1,065.62 | 72.02 |
Last | 6.3960 | 335.50 | 492.71 | 1,070.76 | 72.68 |
Change | -1.2585 | +4.21 | +1.14 | +7.16 | +0.12 |
% Change | -16.44% | +1.27% | +0.23% | +0.67% | +0.17% |
Volume | 1,796,440 | 315,739 | 221,964 | 61,295 | 839,838 |
20-Day Average Volume | 1,469,975 | 2,016,609 | 1,101,502 | 413,892 | 6,273,432 |
Previous Close | 7.6545 | 331.29 | 491.57 | 1,063.60 | 72.56 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 0.5057 | 321.00 | 481.95 | 1,064.40 | 69.79 |
20-Day Raw Stochastic | 16.57% | 89.23% | 94.46% | 62.43% | 73.74% |
20-Day Relative Strength | 32.97% | 68.27% | 68.15% | 58.06% | 63.33% |
Weighted Alpha | -64.50 | +41.78 | +44.74 | +42.50 | -4.49 |
Today's Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
Previous Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
Last Month's Opinion | 72% Sell | 100% Buy | 100% Buy | 100% Buy | 64% Sell |
Performance | |||||
5-Days | |||||
%Chg | -16.39% since 09/07/22 | +1.60% since 07/15/24 | +1.24% since 07/15/24 | -1.06% since 07/15/24 | +2.50% since 07/15/24 |
Low | 0.3820 on 09/14/22 | 328.00 on 07/16/24 | 478.78 on 07/17/24 | 1,060.74 on 07/19/24 | 70.33 on 07/16/24 |
High | 0.6500 on 09/14/22 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,100.08 on 07/16/24 | 74.92 on 07/18/24 |
1-Month | |||||
%Chg | -20.63% since 08/12/22 | +8.85% since 06/21/24 | +6.03% since 06/21/24 | +1.66% since 06/21/24 | +2.70% since 06/21/24 |
Low | 0.3820 on 09/14/22 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
High | 0.6500 on 09/14/22 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
3-Month | |||||
%Chg | -14.72% since 06/14/22 | +23.36% since 04/22/24 | +24.26% since 04/22/24 | +18.94% since 04/22/24 | +8.41% since 04/22/24 |
Low | 0.3820 on 09/14/22 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
High | 0.6500 on 09/14/22 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
6-Month | |||||
%Chg | -34.40% since 03/14/22 | +8.15% since 01/22/24 | +12.92% since 01/22/24 | +13.56% since 01/22/24 | -7.46% since 01/22/24 |
Low | 0.3820 on 09/14/22 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
High | 0.7960 on 03/24/22 | 338.98 on 07/18/24 | 498.77 on 07/22/24 | 1,106.16 on 07/12/24 | 81.06 on 01/25/24 |
Key Statistics | |||||
Market Capitalization, $K | 25,833 | 177,715,552 | 126,851,120 | 117,193,824 | 90,399,088 |
Shares Outstanding, K | 60,583 | 536,435 | 258,053 | 110,186 | 1,245,853 |
Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
Annual Net Income | -27,470,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
Last Quarter Net Income | -6,630,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
60-Month Beta | 0.91 | 0.58 | 0.39 | 0.13 | 0.18 |
Per-Share Information | |||||
Most Recent Earnings | -0.11 on 08/04/22 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
Latest Earnings Date | 11/03/22 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
Ratios | |||||
Price/Earnings ttm | 0.00 | 17.77 | 32.41 | 28.76 | 18.24 |